Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Passage Bio Inc (NQ: PASG ) 0.6294 +0.0144 (+2.34%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Passage Bio Inc < Previous 1 2 3 4 5 Next > Passage Bio to Present Updated Interim Data from Imagine-1 Study for GM1 Gangliosidosis at 19th Annual WORLDSymposium™ 2023 February 15, 2023 From Passage Bio Via GlobeNewswire Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) January 20, 2023 From Passage Bio Via GlobeNewswire Expert Ratings for Passage Bio December 15, 2022 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday December 15, 2022 It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday! Via InvestorPlace Passage Bio Stock Jumps After Gene Therapy Study In Lysosomal Storage Disorder December 14, 2022 Via Benzinga Passage Bio: Q1 Earnings Insights May 16, 2022 Passage Bio (NASDAQ:PASG) reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga Earnings Scheduled For May 16, 2022 May 16, 2022 Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 14, 2022 Via Benzinga Passage Bio Announces Positive Interim Clinical Data from First Six Patients with GM1 Gangliosidosis in Imagine-1 Study December 14, 2022 From Passage Bio Via GlobeNewswire Passage Bio Reports Third Quarter 2022 Financial Results and Provides Business Updates November 10, 2022 From Passage Bio Via GlobeNewswire Passage Bio to Present at Guggenheim 4th Annual Immunology & Neurology Day November 08, 2022 From Passage Bio Via GlobeNewswire Passage Bio To Cut Workforce, Prioritize R&D Programs To Reduce Operating Expenses March 15, 2022 Passage Bio Inc (NASDAQ: PASG) will Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022 November 08, 2022 Upgrades Via Benzinga Passage Bio to Report Third Quarter 2022 Financial Results on November 10, 2022 November 03, 2022 From Passage Bio Via GlobeNewswire Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 14, 2022 From Passage Bio Via GlobeNewswire Passage Bio Announces Appointment of William Chou, M.D. as Chief Executive Officer October 10, 2022 From Passage Bio Via GlobeNewswire Newman Ferrara LLP Announces Corporate Governance Investigations of Passage Bio, Inc. (PASG) September 07, 2022 From Newman Ferrara LLP Via Business Wire 12 Health Care Stocks Moving In Tuesday's After-Market Session August 16, 2022 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session August 12, 2022 Via Benzinga Recap Of Thursday's Biotech Catalysts - End Of the Day Summary August 11, 2022 Via Benzinga Passage Bio Commences Initial-Stage Brain Disorder Study August 11, 2022 Passage Bio (NASDAQ: PASG) has dosed the first patient in the global Phase 1/2 upliFT-D clinical trial evaluating PBFT02 for the treatment of patients with frontotemporal dementia (FTD) with granulin... Via Benzinga Preview: Passage Bio's Earnings August 03, 2022 Passage Bio (NASDAQ:PASG) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that Passage Bio... Via Benzinga Passage Bio to Report Second Quarter 2022 Financial Results on August 4, 2022 July 28, 2022 From Passage Bio Via GlobeNewswire This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday August 04, 2022 Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume. Via Benzinga Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session August 03, 2022 Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday. Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session July 08, 2022 Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 7.7% to $2.66 during Friday's after-market session. The market value of their outstanding shares is at $144.4 million. Via Benzinga The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More May 16, 2022 Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from... Via Benzinga 2 Stocks Under $3 Insiders Are Aggressively Buying May 06, 2022 US crude oil futures traded higher on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the... Via Benzinga Stocks That Hit 52-Week Lows On Wednesday April 20, 2022 On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday April 19, 2022 On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was... Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
